glp-1 obesity drug market news today GLP-1 Market Trends and Global Forecasts Report 2025 Federal regulators on Wednesday approved
Description
Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts
Consider adding either GLP-1 RA or tirzepatide, either as part of initial therapy or as first add-on, to achieve individualised glycaemic target
Zhang T, Tong X, Zhang S, et al
doi: 10.3390/antiox10081175 [DOI] [PMC free article] [PubMed] [Google Scholar] 29
Growing healthcare spending and insurance coverage are supporting wider accessibility to these therapies
Why the anti-obesity drug market could grow to $100 billion by 2030
